These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
833 related articles for article (PubMed ID: 31770391)
1. Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study. Kennedy MC; Hayashi K; Milloy MJ; Wood E; Kerr T PLoS Med; 2019 Nov; 16(11):e1002964. PubMed ID: 31770391 [TBL] [Abstract][Full Text] [Related]
2. Use of on-site detoxification services co-located with a supervised injection facility. Gaddis A; Kennedy MC; Nosova E; Milloy MJ; Hayashi K; Wood E; Kerr T J Subst Abuse Treat; 2017 Nov; 82():1-6. PubMed ID: 29021106 [TBL] [Abstract][Full Text] [Related]
3. Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study. Bouvier BA; Elston B; Hadland SE; Green TC; Marshall BD Harm Reduct J; 2017 Feb; 14(1):13. PubMed ID: 28219388 [TBL] [Abstract][Full Text] [Related]
4. Perceptions about supervised injection facilities among people who inject drugs in Philadelphia. Harris RE; Richardson J; Frasso R; Anderson ED Int J Drug Policy; 2018 Feb; 52():56-61. PubMed ID: 29241143 [TBL] [Abstract][Full Text] [Related]
5. Use of a medically supervised injection facility among street youth. Hadland SE; DeBeck K; Kerr T; Nguyen P; Simo A; Montaner JS; Wood E J Adolesc Health; 2014 Nov; 55(5):684-9. PubMed ID: 24925493 [TBL] [Abstract][Full Text] [Related]
6. Supervised injection facility use and exposure to violence among a cohort of people who inject drugs: A gender-based analysis. Kennedy MC; Hayashi K; Milloy MJ; Boyd J; Wood E; Kerr T Int J Drug Policy; 2020 Apr; 78():102692. PubMed ID: 32200269 [TBL] [Abstract][Full Text] [Related]
7. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study. Marshall BD; Milloy MJ; Wood E; Montaner JS; Kerr T Lancet; 2011 Apr; 377(9775):1429-37. PubMed ID: 21497898 [TBL] [Abstract][Full Text] [Related]
8. Supervised Injection Facility Utilization Patterns: A Prospective Cohort Study in Vancouver, Canada. Kennedy MC; Klassen DC; Dong H; Milloy MS; Hayashi K; Kerr TH Am J Prev Med; 2019 Sep; 57(3):330-337. PubMed ID: 31377091 [TBL] [Abstract][Full Text] [Related]
9. Willingness to access an in-hospital supervised injection facility among hospitalized people who use illicit drugs. Ti L; Buxton J; Harrison S; Dobrer S; Montaner J; Wood E; Kerr T J Hosp Med; 2015 May; 10(5):301-6. PubMed ID: 25754871 [TBL] [Abstract][Full Text] [Related]
10. The willingness of people who inject drugs in Boston to use a supervised injection facility. León C; Cardoso L; Mackin S; Bock B; Gaeta JM Subst Abus; 2018 Jan; 39(1):95-101. PubMed ID: 28799847 [TBL] [Abstract][Full Text] [Related]
11. Use of North America's first medically supervised safer injecting facility among HIV-positive injection drug users. Reddon H; Wood E; Tyndall M; Lai C; Hogg R; Montaner J; Kerr T AIDS Educ Prev; 2011 Oct; 23(5):412-22. PubMed ID: 22010805 [TBL] [Abstract][Full Text] [Related]
13. Acceptability of supervised injection facilities among persons who inject drugs in upstate New York. Duncan E; Shufelt S; Barranco M; Udo T Harm Reduct J; 2022 Jul; 19(1):87. PubMed ID: 35907854 [TBL] [Abstract][Full Text] [Related]
14. The Impact of Benzodiazepine Use on Mortality Among Polysubstance Users in Vancouver, Canada. Walton GR; Hayashi K; Bach P; Dong H; Kerr T; Ahamad K; Milloy MJ; Montaner J; Wood E Public Health Rep; 2016; 131(3):491-9. PubMed ID: 27252569 [TBL] [Abstract][Full Text] [Related]
15. Risk environments facing potential users of a supervised injection site in Ottawa, Canada. Shaw A; Lazarus L; Pantalone T; LeBlanc S; Lin D; Stanley D; Chepesiuk C; Patel S; Tyndall M; Harm Reduct J; 2015 Oct; 12():49. PubMed ID: 26493319 [TBL] [Abstract][Full Text] [Related]
16. Predictors of liver-related death among people who inject drugs in Vancouver, Canada: a 15-year prospective cohort study. Hayashi K; Milloy MJ; Wood E; Dong H; Montaner JS; Kerr T J Int AIDS Soc; 2014; 17(1):19296. PubMed ID: 25391765 [TBL] [Abstract][Full Text] [Related]
17. Acceptability and design preferences of supervised injection services among people who inject drugs in a mid-sized Canadian City. Mitra S; Rachlis B; Scheim A; Bardwell G; Rourke SB; Kerr T Harm Reduct J; 2017 Jul; 14(1):46. PubMed ID: 28709471 [TBL] [Abstract][Full Text] [Related]
18. No association between HIV status and risk of non-fatal overdose among people who inject drugs in Vancouver, Canada. Escudero DJ; Marshall BD; Kerr T; Hayashi K; Feng C; Guillemi SA; Hogg RS; Montaner J; Wood E; Milloy MJ Addict Behav; 2016 Sep; 60():8-12. PubMed ID: 27082262 [TBL] [Abstract][Full Text] [Related]
19. Impact of unstable housing on all-cause mortality among persons who inject drugs. Zivanovic R; Milloy MJ; Hayashi K; Dong H; Sutherland C; Kerr T; Wood E BMC Public Health; 2015 Feb; 15():106. PubMed ID: 25884182 [TBL] [Abstract][Full Text] [Related]
20. The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs. Lake S; Hayashi K; Buxton J; Milloy MJ; Dong H; Wood E; Montaner J; Kerr T Drug Alcohol Depend; 2015 Nov; 156():297-303. PubMed ID: 26454837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]